Table 1.
Descriptive characteristics of the study population at baseline (n = 6861)
| Variables | % | 0 No-shows 3935 (57.4%) |
≥ 1 No-shows 2926 (42.7%) |
|---|---|---|---|
| Age | – | 49 (36, 58) | 41 (31, 52) |
| Income‡ | – | 1928 (600, 10,908) | 1017 (9, 9528) |
| Gender† | |||
| Men | 69.7 | 2742 (69.7) | 2043 (69.8) |
| Women | 29.6 | 1173 (29.8) | 855 (29.2) |
| Transgender | 0.7 | 20 (0.5) | 28 (1.0) |
| Race/ethnicity† | |||
| White | 29.4 | 1326 (33.7) | 688 (23.5) |
| Black | 68.4 | 2508 (63.7) | 2188 (74.8) |
| Other | 2.2 | 101 (2.6) | 50 (1.7) |
| Housing status† | |||
| Permanent/stable | 93.7 | 3780 (96.1) | 2648 (90.5) |
| Temporary/unstable | 6.3 | 155 (3.9) | 278 (9.5) |
| HIV risk factor† | |||
| MSM | 49.3 | 1958 (49.8) | 1421 (48.6) |
| Heterosexual | 45.5 | 1796 (45.6) | 1324 (45.3) |
| Other | 5.3 | 181 (4.6) | 181 (6.2) |
| Site | |||
| 1 | 47.7 | 1995 (50.7) | 1278 (43.7) |
| 2 | 3.6 | 124 (3.2) | 126 (4.3) |
| 3 | 13.7 | 631 (16.0) | 311 (10.6) |
| 4 | – | ||
| 5 | 25.8 | 925 (23.5) | 843 (28.8) |
| 6 | 2.9 | 113 (2.9) | 85 (2.9) |
| 7 | 6.3 | 147 (3.7) | 283 (9.7) |
‡Median (interquartile range); †N (%)
p-value were calculated using Cochran-Mantel–Haenszel test for categorical and Kruskal–Wallis test for continuous variables
Transgender includes individuals transgender, transgender male-to-female, and transgender female-to-male
Other race includes Asian, Native Hawaiian/Pacific Islander, American Indian or Alaska Native, and Other (including mixed race)
Other risk factor includes Injection drug use (IDU), hemophilia/coagulation disorder, receipt of blood transfusion, blood components, or tissue, perinatal transmission, and MSM/IDU